Abstract
Objective: To determine the prevalence of latent tuberculosis infection among Healthcare Workers (HCWs) in Al- Thawra Modern General Hospital. Methods: We carried out cross sectional study to determine the prevalence of Latent Tuberculosis Infection (LTBI) among HCW. Two-steps Tuberculin Skin Test (TST) was performed among health care workers (HCWs) in Al -Thawra Modern General Hospital (TMGH) Sana'a- Yemen during the year 2016. We included all health care workers in the hospital. Out of 466 total HCWs 426 were fulfilled the inclusion criteria. Questionnaire was distributed to HCWs and information related to demographic data, profession, and duration of work, individual and in the family history of Tuberculosis (TB) was recorded. TST was done by a single investigator using the standard Mantoux test. The reaction was read 48 to 72 hours after injection, and the widest axis of indurations was measured by a standardized palpation method. Those with negative result were advised to come, after1- 2 weeks for second step TST. Results: The total number of health workers in the hospital were 466, Eligible cases who fulfilled the including criteria were 426. The remaining either excluded or not present at the time of study. Of them 232 (54.5%) were males and 194 (45.5 %), were females with a ratio of 1.2:1.269 (70%) were positive for TST. The positive result was highest among radiology assistant and laboratory worker represented 91%, 80% respectively, while 76% of doctors found positive for TST. There was an increase in TST reactivity with an older age, and there is a positive correlation between work duration and TST reaction. Conclusion: Latent tuberculosis infection is prominent among HCW who work in high-risk departments. This suggests that some TBI develops via in-hospital infection
Highlights
On 26 September 2018, the United Nations (UN) will hold its first high-level meeting on tuberculosis (TB), at its headquarters in New York
All Member States of WHO and the UN have committed to this goal, initially through their unanimous endorsement of WHO’s End TB Strategy at the World Health Assembly in May 2014 and their adoption of the UN Sustainable Development Goals (SDGs) in September 2015
Effective drug treatments first became available in the 1940s, and in combination with social and economic development they allowed countries in western Europe, North America and some other parts of the world to reduce their burden of TB disease to very low levels.[13]
Summary
On 26 September 2018, the United Nations (UN) will hold its first high-level meeting on tuberculosis (TB), at its headquarters in New York. All Member States of WHO and the UN have committed to this goal, initially through their unanimous endorsement of WHO’s End TB Strategy at the World Health Assembly in May 2014 and their adoption of the UN Sustainable Development Goals (SDGs) in September 2015. The UN high-level meeting follows the first WHO global ministerial conference on ending TB in the SDG era, which was held in November 2017 in the Russian Federation. At the World Health Assembly in May 2018, all WHO Member States committed to accelerate their actions to end TB, building on the Moscow Declaration. New commitments were made by ministers from countries in the WHO South-East Asia Region at the Delhi End TB Summit in March 2018 and by African leaders at a meeting of the African Union in July 2018
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
